Acral lentiginous melanoma: case studies from Kauai. by Charles, J & Elpern, D J
. .. a hiding killer 
Acrallentiginous melanoma: 
Case studies from Kauai 
Jonathan Charles MD* 
David J Elpern MD** 
Cutaneous malignant is generally regarded as a skin cancer 
of Caucasians. However, one subtype, acrallentiginous mela-
noma (AIM), has an equal distribution among all ethnic groups 
and is the variant most common in non-Caucasians. In its early 
stage it is difficult to recognize and, unless diagnosed early, has a 
very poor prognosis. Herein, we present 3 cases of AIM seen on 
Kauai in I990. 
Introduction 
Cutaneous malignant melanoma is increasing in incidence at 
an alarming rate. If this trend continues, it is estimated that the 
incidence of melanoma in all Americans born in the year 2000 will 
be l :901• This estimate apparently refers to Americans of all ethnic 
backgrounds, thus the incidence in Caucasian Americans will be 
substantially higher since melanoma is at least twice as prevalent 
in Caucasians as in non-Caucasians. 
Melanoma is subdivided into 4 clinicopathologic types: 
Superficial spreading, nodular, acrallentiginous (ALM) and lentigo 
maligna melanoma. 
ALM affects the glabrous or non-hair-bearing surfaces of the 
skin and includes the volar aspects of the hands and feet and the 
subungual regions. Superficial spreading and nodular melanoma 
may also affect these locations; however, ALM is the most 
common variant at these sites. Due to its somewhat concealed 
location, it may not be recognized until in an advanced stage. 
ALM affects Caucasians and non-Caucasians to the same 
extent. However, the overall number of cases of melanoma is 
much less in non-Caucasians so the relative percentage of ALM is 
higher in this group. 
We report on 3 cases of ALM all seen in patients of pre-
dominantly Filipino ancestry on Kauai during 1990. 
Case Histories 
Case 1 is a 66-year-old Filipina who presented to her family 
physician with what appeared to be an area of infection measuring 
8 mm in diameter on the instep of the sole of her right foot. She 
was treated with antibiotics; however, the skin lesion did not 
resolve. The clinical impression was then changed to a trauma-
tized plantar wart. Wisely, a skin biopsy was performed; a 
histologic diagnosis of ALM was made and the patient underwent 
a wide local excision with grafting (Fig 1 ). There was no evidence 
of metastasis and the patient is doing well. 
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Case 2 is a 49-year-old Filipino/Hawaiian man who pre-
sented to his doctor with a 2 em dirty ulcer on the heel of his right 
foot. The patient, unable to give a good history, stated that the ulcer 
had been present "for l 0 years" and it bothered him when he drove 
his truck. A biopsy was interpreted as ALM (Fig 2). The patient 
is currently undergoing further treatment elsewhere. 
Case 3 is a 32-year-old Filipina who presented to the emer-
gency room complaining of tightness in her right foot while 
jogging. She stated that a "mole" had been present on her left 4th 
toe for the past year. She had lost 30 pounds in weight in the past 
4 months and suffered from anorexia, nausea and vomiting during 
the past month. Physical examination revealed an ulcerated, dark-
brown nodule on the dorsomedial aspect of herleft 4th toe (Fig 3). 
She had multiple subcutaneous nodules measuring up to 4 em in 
diameter over her body. A biopsy confirmed the clinical suspicion 
of ALM. CT -scan disclosed metastases to the eye and cerebrum. 
The patient died one month later. No autopsy was performed. 
Discussion 
The number of cases of melanoma increases every year. 
Approximately 27,600 new cases of melanoma are expected to be 
diagnosed in the U.S. this year. The 5-year survival rate in the 
U.S. has improved from 43% in the 1930s to 83% in 19832• 
Despite this improvement, mortality has more than doubled over 
the same time period due to the increase in the incidence. A 3- to 
4-fold increase in incidence has been reported in the 20-year 
period 1960 to 1980; for example, in both Japan and Hawaii3·4. 
This increase pertains to all 4 subtypes of melanoma. 
Fig. I - Case I . Wide local excision of plantar ALM. 
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ACRAL LENTIGINOUS MELANOMA (Continued from page 235) 
In the mid-1970s, RJ Reed categorized ALM as a separate 
subtype of melanoma based on its anatomic sites of predilection 
and its distinct histology5• There is a great ethnic/racial variation 
in the percentage of melanomas that are of the ALM type. It is 
highest in Africans and African-Americans (upward of76%) and 
lowest in whites (less than 10% )6·7·8•9•10• The remainder of the 
ethnic groups fall between these extremes. Of note is the fact that 
Chinese, Japanese, Southeast Asians (including Filipinos) and 
Polynesians are predominantly in the upper portion of this inter-
mediate zone of distribution; with cases of ALM ranging between 
29% to 74% of all cases of melanoma in these ethnic groups 4·6•7•9·10• 
ALM has a peak age incidence in the seventh decade of life 
in man and in the sixth decade in women'. The other 3 subtypes 
of melanoma are linked to intermittent sun exposure and burning; 
however, the etiology of ALM is uncertain''· Neither trauma nor 
pigmented nevi appear to predispose to ALW·8·9.12. 
Caucasians are most prone to develop melanoma and this 
predisposition is indirectly proportional to the amount of pigment 
in the skin. For instance, the incidence is highest in red-headed 
Caucasians who freckle easily. Blacks and other darker-skinned 
races have ahigherpercentage of distribution of melanomas on the 
palmar-plantar surfaces, although the actual incidence at that site 
is very similar for all races since skin in these areas is relatively 
depigmented. Thus, non-pigmented skin in whites and non-
whites is the most likely to develop melanoma. 
Plantar melanoma outnumbers palmar melanoma by a factor 
of 17: I P. In its early stages of radial growth, it appears as a 
variably pigmented, brown macule with subtly asymmetric, ir-
regular, notched borders (Fig 4). This stage may last for several 
months or years; then, there occurs a rapid change to the vertical 
phase of growth, heralded by a dark nodule (Figs 1,3,5). Since 
glabrous skin can extend medially and laterally around the digits, 
ALM also may arise on dorsolateral surfaces of the hands and feet 
(Fig 3,5). Longitudinal dark-striations in the nail bed or peri-
onychium (Hutchinson's sign) may herald a subungal ALM. 
It is difficult to recognize ALM during the radial growth 
phase but excisional treatment at this stage offers an excellent 
prognosis. During radial growth, and in the later vertical growth 
phase, plantar ALM can be misdiagnosed as a nevus, plantar wart, 
Fig. 2- Case 2. Plantar ALM. High power. H&E stain. 
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com, callus, infected site of trauma (with hemosiderin deposition), 
hematoma, pyofenic franuloma, or even a focal area of gangrene. 
A high index of suspicion is needed to make the diagnosis. Any 
atypical lesion of the plantar surface, especially one with irregular 
borders or ulceration, should be biopsied. 
In the majority of cases, ALM has a distinct histologic 
appearance (Fig 2). There is marked hyperplasia of atypical 
melanocytes with long dendritic processes along the base of the 
epidermis. Unlike other subtypes of melanoma, there is usually 
little if any migration by the atypical melanocytes into the upper 
epidermis. There is thickening (acanthosis) of the epidermis and 
irregular, wide elongation of the rete ridges. In its vertical growth 
phase, a predominance of atypical spindle cells with increased 
mitoses extend downward into a desmoplastic dermis. 
The prognosis in ALM compares favorably with other subtypes 
of melanoma if the depth of invasion is minimal1•2•13• However, 
ALM is usually diagnosed rather late due to its obscure location 
and ill-defmed appearance; thus, it carries an overall poor prog-
nosis. Blacks have a worse prognosis than whites with 5- and 10-
year survival rates being 18% and 18% for blacks and 72% and 
16% for whites8•13• The 5-year survival rate of ALM in Japan, 
according to one study, was 29% as compared to 39% for all 
melanomas3• 
Prognostic indicators in ALM are similar to that in other 
melanomas and include: Depth of invasion (Clark's dermal or 
subcutaneous level of invasion and Breslow's measured depth of 
thickness); ulceration (if present, it carries a worse prognosis); 
stage (involvement oflyrnph nodes, presence of distantmetastates ); 
and mitotic rate or index (an increased number of mitoses lowers 
the chance of survival)2•14•15 • 
The depth of invasion is considered to be the prognostic factor 
of greatest significance. Both Oark level I (tumor confmed to the 
epidermis and its appendages) and Breslow depth of invasion less 
than 0.76 mm carry a 10-year survival rate of greater than 95%2. 
According to the staging system of melanoma by the American 
Joint Committee on Cancer (that takes into account depth of 
invasion, lymph node involvement and metastases), the 5- and 10-
year survival rates for Stage I (Clark level III or less; depth of 
invasion less than 1.5 mm; no lymph node or distant metastasis) 
Fig. 3 - Case 3. ALM of foot, dorsomedial extension. 
(Continued on page 239) >-
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are 97% and 95% respectively2• 
The major drawback in using these prognostic criteria for 
ALM is that in most cases the level of invasion into the soles or 
palms is difficult to assess, since the normal increased thickness of 
the epidermis in these locations exaggerates the uue Breslow 
depth of invasion. There also is poor demarcation between the 
papillary and reticular dermis at these loci with little, if any, 
subcutaneous fat present and thus assignment to the Clark level is 
usually arbitrary. 
The treatment of ALM is wide, local excision or amputa-
tion 13·16• Elective regional lymph node dissection (without clinical 
evidence of tumor involvement) is generally not indicated. Lymph 
node dissection is not recommended in the case of widespread 
metastases. 
In advanced stages chemotherapy, immunotherapy (most 
noteworthy, interleukin-2), hormonal therapy (melanocyte-
stimulating hormone targeting of cytotoxic agents), and fast 
neutron therapy are used in a few specialized treatment centers; 
however, the prognosis at these stages is generally very poor. 
Melanoma is generally regarded as radioresistant. 
Early diagnosis and surgery offer the best chance of cure. 
Unfortunately, as illustrated in our case number 2 and 3, patients 
may not be aware there is a lesion on the sole of their foot and, if 
so, most often associate it with trauma. Soles and palms should be 
checked during a general physical examination. If a pigmented or 
nonpigmented lesion with the diagnostic criteria suggesting ALM 
is discovered, it should be biopsied17 • Saida and Yoshida recom-
mend that any pigmented lesion on the sole of the foot greater than 
7 mm in diameter should be biopsied18• This biopsy should be 
wide and deep enough for the pathologist to be able to interpret the 
histologic findings. 
All melanomas are increasing in incidence. ALM is elusive 
and proportionately forms a greater percentage of melanomas in 
non whites. Its prognosis is worse than for other types of 
melanoma. Only a careful physical examination, a high index of 
suspicion and early diagnosis will lower its high mortality rate. 
Fig. 4 - Plantar ALM, relatively early stage. 
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Fig. 5 - ALM of hand, dorsomedial extension. 
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A Medical Record (Continued from page 230) 
and organized medicine to be prepared in 
the event of impending war at a time when 
Hawaii was a territory of the U.S., way out 
in the Pacific ocean and when communi-
cation between Washington and the Pa-
cific military outposts of Pearl Harbor, 
Schofield Barracks and Wheeler Air Force 
Base was rather erratic and slow. This bit 
of medical history of that era, now 50 years 
behind us, has never received much men-
tion heretofore. 
It was not possible to have this pub-
lished by Pearl Harbor's 50th anniversary 
last year, despite Rod's efforts, but it will 
celebrate the 51 stremembrance. Rod West 
is to be commended for his considerable 
contribution to Hawaii's history and for 
this accolade to that generation of Hawaii's 
physicians. 
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A Mammogram: 
A Picture That Could 
Save Your Life 
If someone told you that simply 
having your picture taken could save 
your life, would you do it? Of course. 
A mammogram, which can detect 
breast cancer in its earliest, most 
treatable stages, is just that-a pic-
ture-an x-ray of the breast that can 
save your life. 
One in 9 women will develop 
breast cancer at some point in her 
life, but mammography can help 
you beat the odds. Here are 3 key 
tips from the National Cancer Insti-
tute (NCI): 
When you turn 40, have a 
mammogram every 1 to 2 years 
and, when you turn 50, have one 
once a year. You should also have 
annual physical breast exams by a 
doctor and do monthly breast self-
exams. 
Ask your doctor to make an ap-
pointment for you to get a 
mammogram at a quality facility, or 
call a local hospital or health clinic to 
arrange an appointment. The pro-
cedure is simple. 
Don't fear the results of a 
mammogram. For those women 
who do have breast cancer, there 
are several effective treatment op-
tions. Up to 90 percent of these 
women will survive breast cancer 
when it is found and treated early, 
before it has spread beyond the 
breast. 
If you have any questions, call 
NCI' s toll-free Cancer Information 
Service at 1-800-4-CANCER. 
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